MetaCap

Humana (HUM) vs Illumina (ILMN)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Humana (HUM) has outperformed Illumina (ILMN) over the past year, gaining 71.7% versus a gain of 55.7%. Over five years, HUM leads with a -9.0% price change compared with -46.4% for ILMN. Humana is the larger company by market cap ($46.84 billion vs $29.15 billion), about 1.6 times the size.

On valuation, Humana trades at a lower forward P/E (21.1x vs 31.2x for Illumina). Humana pays a dividend yielding 0.91%, while Illumina does not currently pay one. Illumina converts more of its revenue into profit, with a net margin of 19.6% versus 0.9%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

HUM+71.73%ILMN+55.69%
+145%+55%-36%
Nov 21, 20251 yearNov 20, 2026
HUM-10.32%ILMN-47.75%
+33%-27%-86%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

HUM versus ILMN key metrics
MetricHUMILMN
Share price$390.00$192.82
Market cap$46.84B$29.15B
1-day change+2.63%-3.90%
YTD return+52.27%+47.01%
1-year return+71.73%+55.69%
5-year return-8.98%-46.40%
P/E ratio (TTM)38.0533.19
Forward P/E21.0631.19
EPS (TTM)$10.25$5.81
Dividend yield0.91%0.00%
Annual dividend$3.54$0.00
Revenue (latest FY)$129.66B$4.34B
Revenue growth (YoY)+10.11%-0.66%
Net income (latest FY)$1.19B$850.00M
Gross margin—66.08%
Operating margin2.09%18.58%
Net margin0.92%19.57%
52-week high$462.87$309.35
52-week low$163.11$112.65
Distance from 52-week high-15.74%-37.67%
Analyst consensusbuybuy
Avg. price target upside+30.98%+35.59%
Average volume1.46M2.82M
Shares outstanding120.10M151.20M
Employees67,0608,600
SectorHealth CareHealth Care
IndustryMedical SpecialitiesMedical Specialities

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • HUM has outperformed ILMN by 16.0 percentage points over the past year.
  • Illumina is more profitable, keeping 19.6 cents of every revenue dollar as net income versus 0.9 cents for Humana.
  • Humana grew revenue faster in its latest fiscal year (+10.11% vs -0.66%).

About Humana

HUM stock →

Humana Inc. provides medical and specialty insurance products in the United States.

Health Care · Medical Specialities · 67,060 employees

About Illumina

ILMN stock →

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

Health Care · Medical Specialities · 8,600 employees

HUM vs ILMN FAQ

Which is bigger, Humana or Illumina?

Humana (HUM) is larger, with a market capitalization of $46.84B compared with $29.15B for Illumina (ILMN).

Which stock has performed better over the past year, HUM or ILMN?

HUM returned +71.73% over the past 12 months, compared with +55.69% for ILMN (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, HUM or ILMN?

ILMN has the lower trailing P/E at 33.2, versus 38.0 for HUM. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Which pays a higher dividend, Humana or Illumina?

Humana pays a dividend yielding 0.91%, while Illumina does not currently pay a regular dividend.

Are Humana and Illumina in the same industry?

Yes. Both are classified in the Medical Specialities industry within the Health Care sector.

More comparisons